Invitae Corporation (NVTA) |
| 0.019 -0.011 (-35.59%) 02-14 15:59 |
| Open: | 0.0172 |
| High: | 0.024 |
| Low: | 0.016 |
| Volume: | 22,459,258 |
| Market Cap: | 5(M) |
| PE Ratio: | -0 |
| Exchange: | New York Stock Exchange |
| Industry: | Medical - Diagnostics & Research |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 0.02 |
| Resistance 1: | 0.01 |
| Pivot price: | 0.01 |
| Support 1: | 0.00 |
| Support 2: | 0.00 |
| 52w High: | 2.34 |
| 52w Low: | 0.015 |
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California.
| EPS | -5.360 |
| Book Value | -3.780 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | -299.14 |
| Operating Margin (%) | -84.87 |
| Return on Assets (ttm) | -23.7 |
| Return on Equity (ttm) | 0.0 |
Thu, 08 Aug 2024
Invitae completes asset sale to Labcorp amid bankruptcy - Investing.com
Wed, 24 Apr 2024
Invitae Enters into Agreement with Labcorp for Sale of Business - PR Newswire
Mon, 05 Feb 2024
SoftBank-Backed Genetic Testing Invitae's Descent from $7B Valuation to Near-Bankruptcy - Yahoo Finance
Mon, 05 Feb 2024
Why Is Invitae (NVTA) Stock Down 75% Today? - InvestorPlace
Tue, 30 Jan 2024
Invitae Partners with BridgeBio Pharma to Harness Genetic Insights for the Discovery of Rare Disease Therapeutics - PR Newswire
Mon, 29 Jan 2024
Is Invitae Stock a Buy Now? - The Motley Fool
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |